Roflumilast Tablet
Product Images NDC 69292-630

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 69292-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amici Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mcg-20tbl (Roflumilast 250mcg 20tbl)

Packaging label for Roflumilast Tablets 250 mcg, oral tablets by Amici Pharma Inc. The carton displays the proprietary and generic name, strength of 250 mcg per tablet, quantity of 20 tablets (2 x 10 unit-dose), NDC 69292-630-20, along with instruction for pharmacists to dispense the Medication Guide separately.*

FDA Label Image

250mcg-28tbl (Roflumilast 250mcg 28tbl)

Roflumilast Tablets 250 mcg oral tablets packaging label from Amici Pharma Inc. The label indicates a 28-day pack containing 28 tablets (2 x 14 blister cards). It includes the NDC 69292-630-28 and instructs pharmacists to dispense the medication guide separately. The packaging is designed with text and barcode details on a white background.*

FDA Label Image

500mcg-30tbl (Roflumilast 500mcg 30tbl)

The image shows a medication label for Roflumilast Tablets with a strength of 500 mcg. It is labeled for oral use and distributed by Amici Pharma Inc. The package contains 30 tablets. The label includes the NDC number 69292-631-30 and instructions that pharmacists should dispense the Medication Guide separately. There is a barcode and storage information specifying temperature limits.*

FDA Label Image

500mcg-90tbl (Roflumilast 500mcg 90tbl)

Roflumilast Tablets 500 mcg oral tablets packaging label from Amici Pharma Inc. The label includes dispensing information, dosage strength, 90 count, and a barcode. It states the medication is prescription only and includes storage instructions and warnings to keep the product out of reach of children.*

FDA Label Image

Figure (Figure1)

A chart showing the fold change in Cmax and AUC (90% confidence intervals) for Roflumilast and Roflumilast N-oxide when coadministered with various drugs. The chart categorizes drug interactions with recommendations: 'Use With Caution,' 'No Dose Adjustment,' and 'Not Recommended,' listing specific drugs for each group.*

FDA Label Image

Structure (Structure)

Chemical structure of roflumilast, illustrating its molecular framework with fluorine atoms, aromatic rings, oxygen, nitrogen, chlorine atoms, and a cyclopropyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.